Journal of Neuroinfectious Diseases
Open Access

Abstract

Attention Deficit Hyperactivity Disorder is a neurobehavioral disorder most commonly diagnosed in childhood or adolescence but often extends well into adulthood. It is a complex neurological disorder which involves several neurotransmitters and multiple regions of the brain. It often co occurs with other psychiatric disorders like anxiety, mood and behavioural disorders. There are both pharmacological and non-pharmacological treatments available for the treatment of ADHD. The pharmacological treatment is in turn divided into two main categories, stimulants and nonstimulants. The stimulant medications are often the first choice but some non-stimulant medications can also be very effective in the management of ADHD. The purpose of presenting this poster is to open a discussion about the new advances including current and upcoming treat options, how they compare with each other and the pros and cons of using these pharmacological agents.

Biography

Rahila Idris Qazi graduated from Dow University of Health Science, Karachi, Pakistan. She completed her psychiatry residency training at SUNY Buffalo, New York with award as a distinguished resident and then completed her two years fellowship in Child and Adolescent Psychiatry at Indiana University School of Medicine, Indiana. She has been practicing psychiatry in the state of Indiana for more than 20 years and is Board Certified in Adult as well as Child and Adolescent Psychiatry. She is the medical director of her private psychiatry practice and is also affiliated with Meridian health services which are a well reputed FQHC in the state of Indiana. She has extensive experience in working with adults and children with ADHD, Autism spectrum disorder, mood and anxiety disorders, psychosis and substance abuse disorders. She is a respected and well known speaker and has presented in multiple settings like medical conferences, schools, universities, church, synagogues etc in United States, Pakistan and UAE.